LinkedIn Share

Pharmaceutical and Cosmetics Industry Days

Pharmaceutical and Cosmetics Industry Days | June 16-18, 2026 | Warsaw (POL)

PCI Days 2026 - Pharmaceutical and Cosmetics Industry Days - Meet Mabion Expert

PCI Days 2026, Poland’s leading business event dedicated to the pharmaceutical and cosmetics industries, will take place at EXPO XXI in Warsaw. From June 16-18, 2026, this key platform for showcasing the latest innovations in pharmaceuticals, laboratory solutions, and digital technologies brings together manufacturers of medicinal products, dietary supplements, and cosmetics, as well as a wide range of technology and service providers. PCI Days 2026 is an excellent opportunity to build valuable, long-term business relationships.

As part of PCI Days 2026, we invite you to a thought-provoking lecture addressing one of the critical challenges facing modern laboratories:

Is your laboratory truly ready for LIMS?

On June 17, 2026 (Day 2), in the Pharmaceutical Conference Zone, Block V: “Data at Work. Analytics, Digitalization, Systems”, Amanda Jabłońska, our Head of the Physicochemical and Biological Analysis Department, will present: “Organizational Readiness for LIMS: The Price of Digitalization and the Loss of Flexibility”.

Laboratory digitalization is often perceived as a matter of implementing a new system. In reality, it is a test of an organization’s operational maturity. Can your existing processes be transferred directly into a LIMS environment? Or has “flexibility” actually meant a lack of defined standards and process control?

During this session at Pharmaceutical and Cosmetics Industry Days, Amanda will explore the importance of prior process organization and standardization and early strategic decisions that prevent costly consequences later. If you are planning a LIMS implementation, currently undergoing laboratory digitalization, or evaluating your organization’s readiness for transformation, this lecture at PCI Days 2026 is not to be missed.

Check out the PCI Days website and dive deep into the pharma industry.